1011P MET and NF2 alterations confer early resistance to first-line alectinib treatment in ALK-rearranged non-small cell lung cancer

作者：Jili Hu, Nan Ding, Yuquan Chen, J. Liu, J. Zhou, Xinyu Xu, Han Bao, Yuhang Song, D. Zhang, Y. Shao, Y. Zhang · 发表于：Annals of Oncology · 年份：2022 · DOI：10.1016/j.annonc.2022.07.1137 · 研究领域：Lung Cancer Treatments and Mutations、Lung Cancer Research Studies、Lung Cancer Diagnosis and Treatment